Showbiz Cheat Sheet
2019 Showbiz Cheat Sheet,
All Rights Reserved.
Articles About astrazeneca
10 Most Controversial Nobel Peace Prize Winners
Pfizer Decides AstraZeneca Isn’t Worth the Trouble — for Now
Will Pfizer Try Again for AstraZeneca?
Pfizer’s Fourth and ‘Final’ Offer for AstraZeneca Fails
New Filings Reveal How Pfizer’s Executives Made Millions in February
The Top 5 Biggest Pharma Deals of 2013
A Look at Pfizer’s Recent Financial Performance
Merger Frenzy: Pfizer Commits to Britain, Allergan Rejects Valeant
Britain Demands Stronger Commitments From Pfizer in AstraZeneca Deal
Paging the Doctor: Is There a Cure for Pfizer?
AstraZeneca Snubs Pfizer, Bayer Grabs Merck Unit: Merger Mania Continues
Is Big Pharma Ready to Jump Into the Marijuana Market?
6 Drugs That Could Move the Pharma Market
Should You Expect More Tax-Related Acquisitions in Biotechnology?
Top 5 Responsible Corporations in the U.S.
AstraZeneca Gives Pfizer the Cold Shoulder
Pharma Drama: Pfizer Fails to Woo AstraZeneca; Valeant Pursues Allergan
Could Pfizer Be Considering a Grab for AstraZeneca’s Cancer Pipeline?
AstraZeneca Says Nexium Is ‘Still Safe’ With Ranbaxy Ingredient
Immune Checkpoint Blocker Race Heats Up
Big Pharma Continues the Race for Electroporation
Obesity Stock Plays That Stand Out From the Crowd
4 Healthcare Stock Stories Supporting Investment Wellness
Apple’s China Speculation, GameStop’s Strong Quarter, and 3 More Hot Stocks
Ford Avoids Big Sedan Recall and 2 Other Hot Stocks to Watch
4 Healthcare Stock Stories to Start Off the Week’s Investment Wellness
Twitter Cools Off, Loeb’s Stake in Sony, and 3 More Hot Stocks
4 Mergers and Acquisitions Stock Stories for a Savvy Friday Read
4 Healthcare Stock Stories Prescribed for Investors Today
Exxon’s Margins Tumble, Time Warner Cable’s Mixed Quarter, and 3 More Hot Stocks
Apple’s New Retail Leader, AstraZeneca’s Latest Buy, and 3 More Hot Stocks
4 Merger and Acquisitions Stock Stories Ready for a Tuesday Appraisal
Analysts: Merck Downgraded to Hold and 3 Other Research Notes to Look At
4 Healthcare Stock Stories Buzzing Away on Wednesday
Microsoft Shareholders Turn on Gates, AstraZeneca’s Injunction Issue, and 3 More Hot Stocks
4 Healthcare Stock Stories for a Tuesday Investment Checkup
4 Healthcare Stock Stories Ready For a Midweek Investment Checkup
Merck Leases Experimental Cancer Drug to AstraZeneca and 2 Other Dow Movers to Watch
4 Healthcare Stock Stories for a Midweek Investment Checkup
4 Mergers and Acquisitions Stock Stories Making Monday Headlines
Here’s How Russia Is Helping Grow the Biotech Sector
Wal-Mart Eyes Africa, Qualcomm’s Plans for Cash Hoard, and 3 More Hot Stocks
3 Healthcare Stock Stories For a Thursday Investment Checkup
4 Healthcare Stock Stories for Tuesday Investment Wellness
China Bribery Scandal: GlaxoSmithKline Says Sorry
4 Healthcare Stock Stories for a Monday Investment Checkup
Microsoft Uses Sprint Help to Launch New Windows Phone and 2 Other Dow Movers to Watch
Has Pfizer Decided Not to Bother with Pricey Onyx?
4 Healthcare Stock Stories For a Monday Investment Checkup
4 Healthcare Stock Stories Ready For a Tuesday Checkup
Tesla to Replace Oracle on Nasdaq 100 and 3 More Hot Stocks
Onyx is on the Prowl for a Pharmaceuticals Partner After Rejecting Amgen’s Low-Ball Offer
Will AstraZeneca Discover Rising Prices?
Apple iPhone Estimates Cut Further, Rio Tinto to Sell Coal Unit, and 3 More Hot Stocks
Rio Is Selling Coal Unit, Barnes & Noble Needs Help: Morning Buzzers
Apple Target Price Slashed, GlaxoSmithKline Diabetes Drug is Not That Great, and 3 More Hot Stocks
Is AstraZeneca’s String of Pearls Strategy Working?